 MIAMI, March 09, 2022 GLOBE NEWSWIRE -- Fortress Biotech, Inc. NASDAQ: FBIO Fortress, an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in three investor conferences in March 2022. 